Advanced search
1 file | 375.95 KB Add to list

In vitro susceptibility of Burkholderia cepacia complex isolated from cystic fibrosis patients to ceftazidime-avibactam and ceftolozane-tazobactam

Author
Organization
Abstract
We tested the in vitro susceptibility of ceftazidime-avibactam and ceftolozane-tazobactam and 13 other antibiotics against 91 Burkholderia cepacia complex (BCC) strains isolated from cystic fibrosis patients since 2012. The highest susceptibility (82%) was found for trimethoprim-sulfamethoxazole. Eighty-one and 63% of all BCC strains were susceptible to ceftazidime-avibactam and ceftolozane-tazobactam, respectively. For temocillin, ceftazidime, piperacillin-tazobactam, and meropenem, at least 50% of the strains were susceptible. B. stabilis seems to be more resistant than other BCC species.
Keywords
Burkholderia cepacia complex, cystic fibrosis, ceftazidime-avibactam, ceftolozane-tazobactam, in vitro susceptibility, BETA-LACTAMASES, ANTIMICROBIAL SUSCEPTIBILITY, PSEUDOMONAS-AERUGINOSA, ANTIBIOTIC-RESISTANCE, DISK DIFFUSION, TEMOCILLIN, INFECTIONS, CENOCEPACIA, COMBINATION, BACTERIA

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 375.95 KB

Citation

Please use this url to cite or link to this publication:

MLA
Van Dalem, A et al. “In Vitro Susceptibility of Burkholderia Cepacia Complex Isolated from Cystic Fibrosis Patients to Ceftazidime-avibactam and Ceftolozane-tazobactam.” ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 62.9 (2018): n. pag. Print.
APA
Van Dalem, A, Herpol, M., Echahidi, F., Peeters, C., Wybo, I., De Wachter, E., Vandamme, P., et al. (2018). In vitro susceptibility of Burkholderia cepacia complex isolated from cystic fibrosis patients to ceftazidime-avibactam and ceftolozane-tazobactam. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 62(9).
Chicago author-date
Van Dalem, A, M Herpol, F Echahidi, Charlotte Peeters, I Wybo, E De Wachter, Peter Vandamme, and D Piérard. 2018. “In Vitro Susceptibility of Burkholderia Cepacia Complex Isolated from Cystic Fibrosis Patients to Ceftazidime-avibactam and Ceftolozane-tazobactam.” Antimicrobial Agents and Chemotherapy 62 (9).
Chicago author-date (all authors)
Van Dalem, A, M Herpol, F Echahidi, Charlotte Peeters, I Wybo, E De Wachter, Peter Vandamme, and D Piérard. 2018. “In Vitro Susceptibility of Burkholderia Cepacia Complex Isolated from Cystic Fibrosis Patients to Ceftazidime-avibactam and Ceftolozane-tazobactam.” Antimicrobial Agents and Chemotherapy 62 (9).
Vancouver
1.
Van Dalem A, Herpol M, Echahidi F, Peeters C, Wybo I, De Wachter E, et al. In vitro susceptibility of Burkholderia cepacia complex isolated from cystic fibrosis patients to ceftazidime-avibactam and ceftolozane-tazobactam. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2018;62(9).
IEEE
[1]
A. Van Dalem et al., “In vitro susceptibility of Burkholderia cepacia complex isolated from cystic fibrosis patients to ceftazidime-avibactam and ceftolozane-tazobactam,” ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 62, no. 9, 2018.
@article{8617653,
  abstract     = {We tested the in vitro susceptibility of ceftazidime-avibactam and ceftolozane-tazobactam and 13 other antibiotics against 91 Burkholderia cepacia complex (BCC) strains isolated from cystic fibrosis patients since 2012. The highest susceptibility (82%) was found for trimethoprim-sulfamethoxazole. Eighty-one and 63% of all BCC strains were susceptible to ceftazidime-avibactam and ceftolozane-tazobactam, respectively. For temocillin, ceftazidime, piperacillin-tazobactam, and meropenem, at least 50% of the strains were susceptible. B. stabilis seems to be more resistant than other BCC species.},
  articleno    = {e00590-18},
  author       = {Van Dalem, A and Herpol, M and Echahidi, F and Peeters, Charlotte and Wybo, I and De Wachter, E and Vandamme, Peter and Piérard, D},
  issn         = {0066-4804},
  journal      = {ANTIMICROBIAL AGENTS AND CHEMOTHERAPY},
  keywords     = {Burkholderia cepacia complex,cystic fibrosis,ceftazidime-avibactam,ceftolozane-tazobactam,in vitro susceptibility,BETA-LACTAMASES,ANTIMICROBIAL SUSCEPTIBILITY,PSEUDOMONAS-AERUGINOSA,ANTIBIOTIC-RESISTANCE,DISK DIFFUSION,TEMOCILLIN,INFECTIONS,CENOCEPACIA,COMBINATION,BACTERIA},
  language     = {eng},
  number       = {9},
  pages        = {5},
  title        = {In vitro susceptibility of Burkholderia cepacia complex isolated from cystic fibrosis patients to ceftazidime-avibactam and ceftolozane-tazobactam},
  url          = {http://dx.doi.org/10.1128/aac.00590-18},
  volume       = {62},
  year         = {2018},
}

Altmetric
View in Altmetric
Web of Science
Times cited: